Repare Therapeutics Inc [NASDAQ: RPTX] closed the trading session at $3.79.
The stocks have a year to date performance of -48.08 percent and weekly performance of 14.85 percent. The stock has been moved at -13.27 percent over the last six months. The stock has performed -3.81 percent around the most recent 30 days and changed -51.60 percent over the most recent 3-months.
If compared to the average trading volume of 125.98K shares, RPTX reached to a volume of 4575073 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Repare Therapeutics Inc [RPTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RPTX shares is $15.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RPTX stock is a recommendation set at 1.43. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stifel have made an estimate for Repare Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 09, 2023. While these analysts kept the previous recommendation, Morgan Stanley dropped their target price from $28 to $15. The new note on the price target was released on February 03, 2023, representing the official price target for Repare Therapeutics Inc stock. Previously, the target price had yet another raise to $28, while CapitalOne analysts kept a Overweight rating on RPTX stock.
The Average True Range (ATR) for Repare Therapeutics Inc is set at 0.31, with the Price to Sales ratio for RPTX stock in the period of the last 12 months amounting to 1.64. The Price to Book ratio for the last quarter was 0.69, with the Price to Cash per share for the same quarter was set at 5.58.
RPTX stock trade performance evaluation
Repare Therapeutics Inc [RPTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.85. With this latest performance, RPTX shares dropped by -3.81% in over the last four-week period, additionally sinking by -13.27% over the last 6 months – not to mention a drop of -63.63% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RPTX stock in for the last two-week period is set at 52.32, with the RSI for the last a single of trading hit 63.35, and the three-weeks RSI is set at 45.97 for Repare Therapeutics Inc [RPTX]. The present Moving Average for the last 50 days of trading for this stock 4.45, while it was recorded at 3.45 for the last single week of trading, and 6.66 for the last 200 days.
Repare Therapeutics Inc [RPTX]: An insightful look at the core fundamentals
Repare Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.33 and a Current Ratio set at 8.33.
Repare Therapeutics Inc [RPTX]: Institutional Ownership
The top three institutional holders of RPTX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in RPTX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in RPTX stock with ownership which is approximately 5.8386%.
